Scientists have known for years that unhealthy diets – particularly those that are high in fat and sugar – may cause detrimental changes to…
Alzheimer’s disease affects one in 10 people over the age of 65 and one in three over the age of 85, and its global…
This week Being Patient did an extensive series of reports on blood tests for Alzheimer’s, because beyond the headlines, there are a lot of…
Nothing is more exciting than when my favorite basketball team, the Toronto Raptors, announced that they were signing a star player that could help…
Dementia doesn’t just affect the brain of a patient. As clinical psychologist, educator, and author Dasha Kiper explores in her new book, the disease…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they can treat the disease sooner. This research involves discovering…
An Alzheimer’s blood biomarker test can’t actually determine whether or not a person has Alzheimer’s disease — but it can help signal to doctors…
Alzheimer’s blood tests: a new frontier in neurodegenerative diagnostics, getting the world a big step closer to earlier, more accessible Alzheimer’s diagnosis. But it’s…
This month is Black History Month. Let’s talk about the impacts that history has on public health in the present: Alzheimer’s doesn’t discriminate, but…
The U.S. is in the midst of a racial reckoning. The COVID-19 pandemic, which took a particularly heavy toll on Black communities, turned a…
What causes Alzheimer’s disease and related forms of progressive dementia? Scientists still don’t know. One leading theory points to beta-amyloid protein — a biomarker…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Caribbean neuroscientist Indira Turney’s research is centered…
Experts estimate that, by 2023, nearly 40 percent of the more than eight million Americans living with Alzheimer’s and related dementias will be Latino…
By 2030, experts estimate that more than 8 million Americans will be living with Alzheimer’s or other forms of dementia. Black Americans will make…
Biogen renounced ownership of their controversial anti-Alzheimer’s drug Aduhelm after years of dismal sales. The company is also halting an ongoing clinical trial set…